Evidence map›Paper›PMID 27844107›Full record

ReviewSeminars in immunopathology2017

Th9 cells in the pathogenesis of EAE and multiple sclerosis.

Wassim Elyaman, Samia J Khoury

Abstract readReview
PubMed Publisher
In one paragraph

Review in Seminars in immunopathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 91 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Th9 cells provide protective TB immunity.Frontiers in immunology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Interleukin 6 SNPGenes · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Wassim ElyamanAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA. welyaman@rics.bwh.harvard.edu.
Samia J KhouryAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.
Brigham and Women's Hospital · US

Funding

Immune Regulation of Neural Stem Cell Program In EAER01AI043496 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI KHOURY, SAMIA J. · 1999 to 2015
$3.9M
Neural Stem Cells and Regulatory T CellsR56AI093838 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI KHOURY, SAMIA J. · 2012 to 2012
$407k
NIAID NIH HHS R01 AI043496NIAID NIH HHS R56 AI093838
6 · The paper itself

Abstract

Interleukin (IL)-9 producing CD4

Indexed as

Adaptive ImmunityAnimalsAutoimmunityCentral Nervous SystemCytokinesEncephalomyelitis, Autoimmune, ExperimentalHumansImmunomodulationInterleukin-9MiceMultiple SclerosisSignal TransductionT-Lymphocytes, Helper-InducerT-Lymphocyte SubsetsCytokinesInterleukin-9AutoimmunityEAEImmune regulationInterleukin-9Multiple sclerosisT helper cells

Identifiers

PMID27844107
OpenAlexW2553006069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.